Description
Eloha Vol.03 is the first hyaluronic acid- (HA)-based filler with a hybrid mono- and biphasic structure. The ratio of mono- and biphasic HA in Eloha Vol.03 is 3 to 7. Due to the special patented R Square technology, Eloha fillers have a unique multilayer structure: the HA gel presents biphasic HA particles inside of monophasic HA particles. Such a structure allows achieving excellent aesthetic results due to the even distribution of the filler in dermal layers and a natural-looking effect. Smooth and ease injection of the Eloha Vol.03 filler, as well as the presence of lidocaine in the composition, makes the procedure painless and comfortable.
Strengths of Eloha:
- the first HA filler with a hybrid biphasic-monophasic structure
- long-lasting and natural-looking esthetic effect due to the special “R Square” technology
- no filler migration to adjacent tissues
- the Eloha series contains three products varying in the ratio of monophasic to biphasic HA depending on the scope of use
- minimized risk of post-injection edema and bruises
Eloha Vol.03 is ideal for face contouring and volumization. The filler is used for deep and ultra-deep injection (subcutaneous and supraperiosteal augmentation).
Scope of Eloha Vol.03:
- lip augmentation
- jawline and chin correction
- facial volumization (forehead, temples, chin, preauricular and cheekbone areas)
- nose bridge/ridge improvement
The aesthetic effect lasts from 12 to 15 months.
Product composition: HA 20 mg/ml, Lidocaine 0.3%
Eloha Vol.03
1 syringe × 1.0 ml, 2 needles per pack
Needle size: 25G, 27G
Manufacturer: DERMAFIRM Co., Ltd., South Korea
